Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 159

1.

Financial and Clinical Impact of Transfer Patients at Major Teaching Hospitals.

Baker MC, Koopman CJ, Landman JH, Alsdurf CR, Gundling RL, Haberman M, Horvath KA, Orlowski JM.

Acad Med. 2019 Jun 25. doi: 10.1097/ACM.0000000000002855. [Epub ahead of print]

PMID:
31246622
2.

Preferential Disruption of Auditory Word Representations in Primary Progressive Aphasia With the Neuropathology of FTLD-TDP Type A.

Mesulam MM, Nelson MJ, Hyun J, Rader B, Hurley RS, Rademakers R, Baker MC, Bigio EH, Weintraub S.

Cogn Behav Neurol. 2019 Mar;32(1):46-53. doi: 10.1097/WNN.0000000000000180.

PMID:
30896577
3.

Gender equity in mass drug administration for neglected tropical diseases: data from 16 countries.

Cohn DA, Kelly MP, Bhandari K, Zoerhoff KL, Batcho WE, Drabo F, Negussu N, Marfo B, Goepogui A, Lemoine JF, Ganefa S, Massangaie M, Rimal P, Gnandou I, Anagbogu IN, Ndiaye M, Bah YM, Mwingira UJ, Awoussi MS, Tukahebwa EM, Stelmach RD, Mingkwan PC, Pou B, Koroma JB, Rotondo LA, Kraemer JD, Baker MC.

Int Health. 2019 Mar 8. pii: ihz012. doi: 10.1093/inthealth/ihz012. [Epub ahead of print]

PMID:
30845318
4.

Eliminating Neglected Tropical Diseases in Urban Areas: A Review of Challenges, Strategies and Research Directions for Successful Mass Drug Administration.

Adams AM, Vuckovic M, Birch E, Brant TA, Bialek S, Yoon D, Koroma J, Direny A, Shott J, Lemoine JF, Dembele M, Baker MC.

Trop Med Infect Dis. 2018 Nov 21;3(4). pii: E122. doi: 10.3390/tropicalmed3040122. Review.

5.

How lymphatic filariasis was eliminated from an urban poor setting in Santo Domingo, Dominican Republic.

Gonzales M, Baker MC, Celestino A, Santa Morillo D, Chambliss A, Adams S, Gyapong M, Kyelem D.

Int Health. 2019 Mar 1;11(2):108-118. doi: 10.1093/inthealth/ihy059.

6.

Dermatomyositis Associated With a Skull Base Chondrosarcoma.

Baker MC, Smith GP, Miloslavsky EM.

J Clin Rheumatol. 2019 Jun;25(4):50-53. doi: 10.1097/RHU.0000000000000732. No abstract available.

PMID:
29664820
7.

Cognitive impairment in progressive supranuclear palsy is associated with tau burden.

Koga S, Parks A, Kasanuki K, Sanchez-Contreras M, Baker MC, Josephs KA, Ahlskog JE, Uitti RJ, Graff-Radford N, van Gerpen JA, Wszolek ZK, Rademakers R, Dickson DW.

Mov Disord. 2017 Dec;32(12):1772-1779. doi: 10.1002/mds.27198. Epub 2017 Oct 30.

8.

Abnormal expression of homeobox genes and transthyretin in C9ORF72 expansion carriers.

Finch NA, Wang X, Baker MC, Heckman MG, Gendron TF, Bieniek KF, Wuu J, DeJesus-Hernandez M, Brown PH, Chew J, Jansen-West KR, Daughrity LM, Nicholson AM, Murray ME, Josephs KA, Parisi JE, Knopman DS, Petersen RC, Petrucelli L, Boeve BF, Graff-Radford NR, Asmann YW, Dickson DW, Benatar M, Bowser R, Boylan KB, Rademakers R, van Blitterswijk M.

Neurol Genet. 2017 Jun 7;3(4):e161. doi: 10.1212/NXG.0000000000000161. eCollection 2017 Aug.

9.

Repetitive element transcripts are elevated in the brain of C9orf72 ALS/FTLD patients.

Prudencio M, Gonzales PK, Cook CN, Gendron TF, Daughrity LM, Song Y, Ebbert MTW, van Blitterswijk M, Zhang YJ, Jansen-West K, Baker MC, DeTure M, Rademakers R, Boylan KB, Dickson DW, Petrucelli L, Link CD.

Hum Mol Genet. 2017 Sep 1;26(17):3421-3431. doi: 10.1093/hmg/ddx233.

10.

Impact of the Lymphatic Filariasis Control Program towards elimination of filariasis in Vanuatu, 1997-2006.

Allen T, Taleo F, Graves PM, Wood P, Taleo G, Baker MC, Bradley M, Ichimori K.

Trop Med Health. 2017 Jun 1;45:8. doi: 10.1186/s41182-017-0047-8. eCollection 2017.

11.

Assessment of Olfactory Function in MAPT-Associated Neurodegenerative Disease Reveals Odor-Identification Irreproducibility as a Non-Disease-Specific, General Characteristic of Olfactory Dysfunction.

Markopoulou K, Chase BA, Robowski P, Strongosky A, Narożańska E, Sitek EJ, Berdynski M, Barcikowska M, Baker MC, Rademakers R, Sławek J, Klein C, Hückelheim K, Kasten M, Wszolek ZK.

PLoS One. 2016 Nov 17;11(11):e0165112. doi: 10.1371/journal.pone.0165112. eCollection 2016.

12.

Field assessment of the impacts of Deepwater Horizon oiling on coastal marsh vegetation of Mississippi and Alabama.

Willis JM, Hester MW, Rouhani S, Steinhoff MA, Baker MC.

Environ Toxicol Chem. 2016 Nov;35(11):2791-2797. doi: 10.1002/etc.3450. Epub 2016 Jul 18.

PMID:
27061832
13.

FTDP-17 with Pick body-like inclusions associated with a novel tau mutation, p.E372G.

Tacik P, DeTure MA, Carlomagno Y, Lin WL, Murray ME, Baker MC, Josephs KA, Boeve BF, Wszolek ZK, Graff-Radford NR, Parisi JE, Petrucelli L, Rademakers R, Isaacson RS, Heilman KM, Petersen RC, Dickson DW, Kouri N.

Brain Pathol. 2017 Sep;27(5):612-626. doi: 10.1111/bpa.12428. Epub 2016 Oct 5.

14.

Impacts of the Deepwater Horizon oil spill on the salt marsh vegetation of Louisiana.

Hester MW, Willis JM, Rouhani S, Steinhoff MA, Baker MC.

Environ Pollut. 2016 Sep;216:361-370. doi: 10.1016/j.envpol.2016.05.065. Epub 2016 Jun 11.

15.

Kids just wanna have fun: Children's experiences of a weight management programme.

Watson LA, Baker MC, Chadwick PM.

Br J Health Psychol. 2016 May;21(2):407-20. doi: 10.1111/bjhp.12175. Epub 2015 Dec 11.

PMID:
26663714
16.

Novel clinical associations with specific C9ORF72 transcripts in patients with repeat expansions in C9ORF72.

van Blitterswijk M, Gendron TF, Baker MC, DeJesus-Hernandez M, Finch NA, Brown PH, Daughrity LM, Murray ME, Heckman MG, Jiang J, Lagier-Tourenne C, Edbauer D, Cleveland DW, Josephs KA, Parisi JE, Knopman DS, Petersen RC, Petrucelli L, Boeve BF, Graff-Radford NR, Boylan KB, Dickson DW, Rademakers R.

Acta Neuropathol. 2015 Dec;130(6):863-76. doi: 10.1007/s00401-015-1480-6. Epub 2015 Oct 5.

17.

Degradation of oil by fungi isolated from Gulf of Mexico beaches.

Simister RL, Poutasse CM, Thurston AM, Reeve JL, Baker MC, White HK.

Mar Pollut Bull. 2015 Nov 15;100(1):327-333. doi: 10.1016/j.marpolbul.2015.08.029. Epub 2015 Aug 29.

PMID:
26323859
18.

Diffuse leukoencephalopathy with spheroids presenting as primary progressive aphasia.

Oboudiyat C, Bigio EH, Bonakdarpour B, Baker MC, Rademakers R, Weintraub S, Mesulam MM.

Neurology. 2015 Aug 18;85(7):652-3. doi: 10.1212/WNL.0000000000001851. Epub 2015 Jul 22. No abstract available.

19.

Distinct brain transcriptome profiles in C9orf72-associated and sporadic ALS.

Prudencio M, Belzil VV, Batra R, Ross CA, Gendron TF, Pregent LJ, Murray ME, Overstreet KK, Piazza-Johnston AE, Desaro P, Bieniek KF, DeTure M, Lee WC, Biendarra SM, Davis MD, Baker MC, Perkerson RB, van Blitterswijk M, Stetler CT, Rademakers R, Link CD, Dickson DW, Boylan KB, Li H, Petrucelli L.

Nat Neurosci. 2015 Aug;18(8):1175-82. doi: 10.1038/nn.4065. Epub 2015 Jul 20.

20.

Jump from pre-mutation to pathologic expansion in C9orf72.

Xi Z, van Blitterswijk M, Zhang M, McGoldrick P, McLean JR, Yunusova Y, Knock E, Moreno D, Sato C, McKeever PM, Schneider R, Keith J, Petrescu N, Fraser P, Tartaglia MC, Baker MC, Graff-Radford NR, Boylan KB, Dickson DW, Mackenzie IR, Rademakers R, Robertson J, Zinman L, Rogaeva E.

Am J Hum Genet. 2015 Jun 4;96(6):962-70. doi: 10.1016/j.ajhg.2015.04.016. Epub 2015 May 21.

21.

A truncating SOD1 mutation, p.Gly141X, is associated with clinical and pathologic heterogeneity, including frontotemporal lobar degeneration.

Nakamura M, Bieniek KF, Lin WL, Graff-Radford NR, Murray ME, Castanedes-Casey M, Desaro P, Baker MC, Rutherford NJ, Robertson J, Rademakers R, Dickson DW, Boylan KB.

Acta Neuropathol. 2015 Jul;130(1):145-57. doi: 10.1007/s00401-015-1431-2. Epub 2015 Apr 28.

22.

A novel tau mutation, p.K317N, causes globular glial tauopathy.

Tacik P, DeTure M, Lin WL, Sanchez Contreras M, Wojtas A, Hinkle KM, Fujioka S, Baker MC, Walton RL, Carlomagno Y, Brown PH, Strongosky AJ, Kouri N, Murray ME, Petrucelli L, Josephs KA, Rademakers R, Ross OA, Wszolek ZK, Dickson DW.

Acta Neuropathol. 2015 Aug;130(2):199-214. doi: 10.1007/s00401-015-1425-0. Epub 2015 Apr 22.

23.

Dominant frontotemporal dementia mutations in 140 cases of primary progressive aphasia and speech apraxia.

Flanagan EP, Baker MC, Perkerson RB, Duffy JR, Strand EA, Whitwell JL, Machulda MM, Rademakers R, Josephs KA.

Dement Geriatr Cogn Disord. 2015;39(5-6):281-6. doi: 10.1159/000375299. Epub 2015 Feb 28.

24.

Brain atrophy over time in genetic and sporadic frontotemporal dementia: a study of 198 serial magnetic resonance images.

Whitwell JL, Boeve BF, Weigand SD, Senjem ML, Gunter JL, Baker MC, DeJesus-Hernandez M, Knopman DS, Wszolek ZK, Petersen RC, Rademakers R, Jack CR Jr, Josephs KA.

Eur J Neurol. 2015 May;22(5):745-52. doi: 10.1111/ene.12675. Epub 2015 Feb 12.

25.

Clinical and neuroimaging biomarkers of amyloid-negative logopenic primary progressive aphasia.

Whitwell JL, Duffy JR, Strand EA, Machulda MM, Senjem ML, Schwarz CG, Reid R, Baker MC, Perkerson RB, Lowe VJ, Rademakers R, Jack CR Jr, Josephs KA.

Brain Lang. 2015 Mar;142:45-53. doi: 10.1016/j.bandl.2015.01.009. Epub 2015 Feb 3.

26.

Genetic modifiers in carriers of repeat expansions in the C9ORF72 gene.

van Blitterswijk M, Mullen B, Wojtas A, Heckman MG, Diehl NN, Baker MC, DeJesus-Hernandez M, Brown PH, Murray ME, Hsiung GY, Stewart H, Karydas AM, Finger E, Kertesz A, Bigio EH, Weintraub S, Mesulam M, Hatanpaa KJ, White CL 3rd, Neumann M, Strong MJ, Beach TG, Wszolek ZK, Lippa C, Caselli R, Petrucelli L, Josephs KA, Parisi JE, Knopman DS, Petersen RC, Mackenzie IR, Seeley WW, Grinberg LT, Miller BL, Boylan KB, Graff-Radford NR, Boeve BF, Dickson DW, Rademakers R.

Mol Neurodegener. 2014 Sep 20;9:38. doi: 10.1186/1750-1326-9-38.

27.

Ataxin-2 as potential disease modifier in C9ORF72 expansion carriers.

van Blitterswijk M, Mullen B, Heckman MG, Baker MC, DeJesus-Hernandez M, Brown PH, Murray ME, Hsiung GY, Stewart H, Karydas AM, Finger E, Kertesz A, Bigio EH, Weintraub S, Mesulam M, Hatanpaa KJ, White CL 3rd, Neumann M, Strong MJ, Beach TG, Wszolek ZK, Lippa C, Caselli R, Petrucelli L, Josephs KA, Parisi JE, Knopman DS, Petersen RC, Mackenzie IR, Seeley WW, Grinberg LT, Miller BL, Boylan KB, Graff-Radford NR, Boeve BF, Dickson DW, Rademakers R.

Neurobiol Aging. 2014 Oct;35(10):2421.e13-7. doi: 10.1016/j.neurobiolaging.2014.04.016. Epub 2014 May 2.

28.

Genetic screening and functional characterization of PDGFRB mutations associated with basal ganglia calcification of unknown etiology.

Sanchez-Contreras M, Baker MC, Finch NA, Nicholson A, Wojtas A, Wszolek ZK, Ross OA, Dickson DW, Rademakers R.

Hum Mutat. 2014 Aug;35(8):964-71. doi: 10.1002/humu.22582. Epub 2014 Jun 3.

29.

Expanded C9ORF72 hexanucleotide repeat in depressive pseudodementia.

Bieniek KF, van Blitterswijk M, Baker MC, Petrucelli L, Rademakers R, Dickson DW.

JAMA Neurol. 2014 Jun;71(6):775-81. doi: 10.1001/jamaneurol.2013.6368.

30.

A novel GRN mutation (GRN c.708+6_+9delTGAG) in frontotemporal lobar degeneration with TDP-43-positive inclusions: clinicopathologic report of 6 cases.

Bit-Ivan EN, Suh E, Shim HS, Weintraub S, Hyman BT, Arnold SE, McCarty-Wood E, Van Deerlin VM, Schneider JA, Trojanowski JQ, Frosch MP, Baker MC, Rademakers R, Mesulam M, Bigio EH.

J Neuropathol Exp Neurol. 2014 May;73(5):467-73. doi: 10.1097/NEN.0000000000000070.

31.

Progranulin-associated PiB-negative logopenic primary progressive aphasia.

Josephs KA, Duffy JR, Strand EA, Machulda MM, Vemuri P, Senjem ML, Perkerson RB, Baker MC, Lowe V, Jack CR Jr, Rademakers R, Whitwell JL.

J Neurol. 2014 Mar;261(3):604-14. doi: 10.1007/s00415-014-7243-9. Epub 2014 Jan 22.

32.

TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia.

van Blitterswijk M, Mullen B, Nicholson AM, Bieniek KF, Heckman MG, Baker MC, DeJesus-Hernandez M, Finch NA, Brown PH, Murray ME, Hsiung GY, Stewart H, Karydas AM, Finger E, Kertesz A, Bigio EH, Weintraub S, Mesulam M, Hatanpaa KJ, White CL 3rd, Strong MJ, Beach TG, Wszolek ZK, Lippa C, Caselli R, Petrucelli L, Josephs KA, Parisi JE, Knopman DS, Petersen RC, Mackenzie IR, Seeley WW, Grinberg LT, Miller BL, Boylan KB, Graff-Radford NR, Boeve BF, Dickson DW, Rademakers R.

Acta Neuropathol. 2014 Mar;127(3):397-406. doi: 10.1007/s00401-013-1240-4. Epub 2014 Jan 3.

33.

Reduced C9orf72 gene expression in c9FTD/ALS is caused by histone trimethylation, an epigenetic event detectable in blood.

Belzil VV, Bauer PO, Prudencio M, Gendron TF, Stetler CT, Yan IK, Pregent L, Daughrity L, Baker MC, Rademakers R, Boylan K, Patel TC, Dickson DW, Petrucelli L.

Acta Neuropathol. 2013 Dec;126(6):895-905. doi: 10.1007/s00401-013-1199-1. Epub 2013 Oct 29.

34.

An adult-onset leukoencephalopathy with axonal spheroids and pigmented glia accompanied by brain calcifications: a case report and a literature review of brain calcifications disorders.

Fujioka S, Broderick DF, Sundal C, Baker MC, Rademakers R, Wszolek ZK.

J Neurol. 2013 Oct;260(10):2665-8. doi: 10.1007/s00415-013-7093-x. Epub 2013 Sep 14. Review. No abstract available.

35.

C9ORF72 repeat expansions in cases with previously identified pathogenic mutations.

van Blitterswijk M, Baker MC, DeJesus-Hernandez M, Ghidoni R, Benussi L, Finger E, Hsiung GY, Kelley BJ, Murray ME, Rutherford NJ, Brown PE, Ravenscroft T, Mullen B, Ash PE, Bieniek KF, Hatanpaa KJ, Karydas A, Wood EM, Coppola G, Bigio EH, Lippa C, Strong MJ, Beach TG, Knopman DS, Huey ED, Mesulam M, Bird T, White CL 3rd, Kertesz A, Geschwind DH, Van Deerlin VM, Petersen RC, Binetti G, Miller BL, Petrucelli L, Wszolek ZK, Boylan KB, Graff-Radford NR, Mackenzie IR, Boeve BF, Dickson DW, Rademakers R.

Neurology. 2013 Oct 8;81(15):1332-41. doi: 10.1212/WNL.0b013e3182a8250c. Epub 2013 Sep 11.

36.

Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): a cross-sectional cohort study.

van Blitterswijk M, DeJesus-Hernandez M, Niemantsverdriet E, Murray ME, Heckman MG, Diehl NN, Brown PH, Baker MC, Finch NA, Bauer PO, Serrano G, Beach TG, Josephs KA, Knopman DS, Petersen RC, Boeve BF, Graff-Radford NR, Boylan KB, Petrucelli L, Dickson DW, Rademakers R.

Lancet Neurol. 2013 Oct;12(10):978-88. doi: 10.1016/S1474-4422(13)70210-2. Epub 2013 Sep 5.

37.

Measuring treatment coverage for neglected tropical disease control programs: analysis of a survey design.

Baker MC, Krotki K, Sankara DP, Trofimovich L, Zoerhoff KL, Courtney L, Chowdhury D, Linehan M.

Am J Epidemiol. 2013 Jul 15;178(2):268-75. doi: 10.1093/aje/kws468. Epub 2013 May 17.

PMID:
23860563
38.

TMEM106B p.T185S regulates TMEM106B protein levels: implications for frontotemporal dementia.

Nicholson AM, Finch NA, Wojtas A, Baker MC, Perkerson RB 3rd, Castanedes-Casey M, Rousseau L, Benussi L, Binetti G, Ghidoni R, Hsiung GY, Mackenzie IR, Finger E, Boeve BF, Ertekin-Taner N, Graff-Radford NR, Dickson DW, Rademakers R.

J Neurochem. 2013 Sep;126(6):781-91. doi: 10.1111/jnc.12329. Epub 2013 Jul 1.

39.

Mutations in protein N-arginine methyltransferases are not the cause of FTLD-FUS.

Ravenscroft TA, Baker MC, Rutherford NJ, Neumann M, Mackenzie IR, Josephs KA, Boeve BF, Petersen R, Halliday GM, Kril J, van Swieten JC, Seeley WW, Dickson DW, Rademakers R.

Neurobiol Aging. 2013 Sep;34(9):2235.e11-3. doi: 10.1016/j.neurobiolaging.2013.04.004. Epub 2013 Apr 28.

40.

Profilin-1 mutations are rare in patients with amyotrophic lateral sclerosis and frontotemporal dementia.

van Blitterswijk M, Baker MC, Bieniek KF, Knopman DS, Josephs KA, Boeve B, Caselli R, Wszolek ZK, Petersen R, Graff-Radford NR, Boylan KB, Dickson DW, Rademakers R.

Amyotroph Lateral Scler Frontotemporal Degener. 2013 Sep;14(5-6):463-9. doi: 10.3109/21678421.2013.787630. Epub 2013 May 2.

41.

The acceptability and feasibility of an intercultural birth center in the highlands of Chiapas, Mexico.

Tucker K, Ochoa H, Garcia R, Sievwright K, Chambliss A, Baker MC.

BMC Pregnancy Childbirth. 2013 Apr 16;13:94. doi: 10.1186/1471-2393-13-94.

42.

A "French twist": practical hair control in plastic surgery.

Baker MC, Fox LC, Davis CR.

Plast Reconstr Surg. 2013 Mar;131(3):456e-7e. doi: 10.1097/PRS.0b013e31827c73d9. No abstract available.

PMID:
23446612
43.

CSF1R mutations link POLD and HDLS as a single disease entity.

Nicholson AM, Baker MC, Finch NA, Rutherford NJ, Wider C, Graff-Radford NR, Nelson PT, Clark HB, Wszolek ZK, Dickson DW, Knopman DS, Rademakers R.

Neurology. 2013 Mar 12;80(11):1033-40. doi: 10.1212/WNL.0b013e31828726a7. Epub 2013 Feb 13.

44.

Comparative sensitivity to environmental variation and human disturbance of Asian tapirs (Tapirus indicus) and other wild ungulates in Thailand.

Lynam AJ, Tantipisanuh N, Chutipong W, Ngoprasert D, Baker MC, Cutter P, Gale G, Kitamura S, Steinmetz R, Sukmasuang R, Thunhikorn S.

Integr Zool. 2012 Dec;7(4):389-399. doi: 10.1111/1749-4877.12002. Erratum in: Integr Zool. 2013 Mar;8(1):121-122.

PMID:
23253370
45.

Bubble nasal CPAP, early surfactant treatment, and rapid extubation are associated with decreased incidence of bronchopulmonary dysplasia in very-low-birth-weight newborns: efficacy and safety considerations.

Friedman CA, Menchaca RC, Baker MC, Rivas CK, Laberge RN, Rios EH, Haider SH, Romero EJ, Eason EB, Fraley JK, Woldesenbet M.

Respir Care. 2013 Jul;58(7):1134-42.

46.

Tau pathology in frontotemporal lobar degeneration with C9ORF72 hexanucleotide repeat expansion.

Bieniek KF, Murray ME, Rutherford NJ, Castanedes-Casey M, DeJesus-Hernandez M, Liesinger AM, Baker MC, Boylan KB, Rademakers R, Dickson DW.

Acta Neuropathol. 2013 Feb;125(2):289-302. doi: 10.1007/s00401-012-1048-7. Epub 2012 Sep 28.

47.

Clinical and electrophysiologic variability in amyotrophic lateral sclerosis within a kindred harboring the C9ORF72 repeat expansion.

Coon EA, Daube JR, Dejesus-Hernandez M, Adeli A, Savica R, Parisi JE, Dickson DW, Josephs KA, Baker MC, Johnson KA, Ivnik RJ, Petersen RC, Knopman DS, Boylan KB, Rademakers R, Boeve BF.

Amyotroph Lateral Scler Frontotemporal Degener. 2013 Mar;14(2):132-7. doi: 10.3109/17482968.2012.724075. Epub 2012 Oct 4.

PMID:
23035801
48.

Frontotemporal dementia in a Brazilian kindred with the c9orf72 mutation.

Takada LT, Pimentel ML, Dejesus-Hernandez M, Fong JC, Yokoyama JS, Karydas A, Thibodeau MP, Rutherford NJ, Baker MC, Lomen-Hoerth C, Rademakers R, Miller BL.

Arch Neurol. 2012 Sep;69(9):1149-53. doi: 10.1001/archneurol.2012.650.

49.

Frontotemporal dementia due to C9ORF72 mutations: clinical and imaging features.

Sha SJ, Takada LT, Rankin KP, Yokoyama JS, Rutherford NJ, Fong JC, Khan B, Karydas A, Baker MC, DeJesus-Hernandez M, Pribadi M, Coppola G, Geschwind DH, Rademakers R, Lee SE, Seeley W, Miller BL, Boxer AL.

Neurology. 2012 Sep 4;79(10):1002-11. doi: 10.1212/WNL.0b013e318268452e. Epub 2012 Aug 8.

50.

Length of normal alleles of C9ORF72 GGGGCC repeat do not influence disease phenotype.

Rutherford NJ, Heckman MG, Dejesus-Hernandez M, Baker MC, Soto-Ortolaza AI, Rayaprolu S, Stewart H, Finger E, Volkening K, Seeley WW, Hatanpaa KJ, Lomen-Hoerth C, Kertesz A, Bigio EH, Lippa C, Knopman DS, Kretzschmar HA, Neumann M, Caselli RJ, White CL 3rd, Mackenzie IR, Petersen RC, Strong MJ, Miller BL, Boeve BF, Uitti RJ, Boylan KB, Wszolek ZK, Graff-Radford NR, Dickson DW, Ross OA, Rademakers R.

Neurobiol Aging. 2012 Dec;33(12):2950.e5-7. doi: 10.1016/j.neurobiolaging.2012.07.005. Epub 2012 Jul 26.

Supplemental Content

Loading ...
Support Center